Market closed
Bruker/$BRKR
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Bruker
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
Ticker
$BRKR
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
9,707
Website
Bruker Metrics
BasicAdvanced
$8.5B
Market cap
27.18
P/E ratio
$2.06
EPS
1.20
Beta
$0.20
Dividend rate
0.36%
Dividend yield
Price and volume
Market cap
$8.5B
Beta
1.2
52-week high
$94.86
52-week low
$54.55
Average daily volume
1.3M
Dividend rate
$0.20
Financial strength
Current ratio
1.658
Quick ratio
0.658
Long term debt to equity
122.864
Total debt to equity
124.643
Dividend payout ratio (TTM)
9.81%
Interest coverage (TTM)
10.46%
Management effectiveness
Return on assets (TTM)
4.51%
Return on equity (TTM)
19.73%
Valuation
Price to earnings (TTM)
27.179
Price to revenue (TTM)
2.548
Price to book
4.7
Price to tangible book (TTM)
-12.24
Price to free cash flow (TTM)
52.713
Dividend yield (TTM)
0.36%
Forward dividend yield
0.36%
Growth
Revenue change (TTM)
15.00%
Earnings per share change (TTM)
-4.69%
3-year revenue growth (CAGR)
11.13%
3-year earnings per share growth (CAGR)
5.19%
3-year dividend per share growth (CAGR)
7.72%
What the Analysts think about Bruker
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Bruker stock.
Bruker Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Bruker Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Bruker News
AllArticlesVideos
Bruker Corporation (BRKR) Q3 2024 Earnings Call Transcript
Seeking Alpha·1 week ago
Bruker Announces Date and Time of Third Quarter 2024 Earnings Release and Webcast
Business Wire·2 weeks ago
Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics
Business Wire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Bruker stock?
Bruker (BRKR) has a market cap of $8.5B as of November 13, 2024.
What is the P/E ratio for Bruker stock?
The price to earnings (P/E) ratio for Bruker (BRKR) stock is 27.18 as of November 13, 2024.
Does Bruker stock pay dividends?
Yes, the Bruker (BRKR) stock pays dividends to shareholders. As of November 13, 2024, the dividend rate is $0.2 and the yield is 0.36%. Bruker has a payout ratio of 9.81% on a trailing twelve-month basis.
When is the next Bruker dividend payment date?
The next Bruker (BRKR) dividend payment date is unconfirmed.
What is the beta indicator for Bruker?
Bruker (BRKR) has a beta rating of 1.2. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.